No recent analyst price targets found for IDXG.
Latest News for IDXG
Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results
PARSIPPANY, NJ, March 30, 2026 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCQX: IDXG) today announced financial results for the fourth quarter and full year ended December 31, 2025 and provided a business and financial update.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for IDXG.
U.S. House Trading
No House trades found for IDXG.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.